Tinzaparin for the prevention of thromboembolic events in ambulatory patients with metastatic colorectal cancer receiving first line treatment: a randomised, clinical trial design

[Background] Colorectal cancer (CRC) is the third most commonly diagnosed cancer worldwide. CRC leads to increased activation of the clotting system. Since CRC patients present a higher rate of bleeding, careful evaluation of the risk/benefits of anticoagulant prophylaxis is necessary.

Detalles Bibliográficos
Autores: Salgado, Mercedes, Camara-Gómez, Juan de la, García-Escobar, Ignacio, Álvarez-Llosa, Renata-Carola, González-Villarroel, Paula, Fernández Garay, David, Pàmpols-Felip, Montse, Guillot-Morales, Mónica, Pelegrín-Mateo, Francisco José, Jiménez-Orozco, Encarnación, Sastre, Javier, Martínez de Castro, Eva, Coma, Eva, París Bouzas, Lorena, Ferrer-Pérez, Ana Isabel, Mompradé-Olivé, Elisabet, Cousillas-Castiñeiras, Antia, Covela-Rúa, Marta, Rojas, Mariam, Querol, Rosa, Robles-Díaz, Luis, Merino, Marta, Gil, Mireia, Sánchez Cánovas, Manuel, Elías, Teresa, Marrupe-González, David, Sánchez-Gil, Belén, Carmona-Campos, Marta, García-Ferrón, María, Soria, José Manuel, Muñoz, Andrés
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2025
País:España
Institución:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/418251
Acceso en línea:http://hdl.handle.net/10261/418251
https://api.elsevier.com/content/abstract/scopus_id/105022125501
Access Level:acceso abierto
Palabra clave:Colorectal cancer
Genetics
Metastatic
Risk factors
Thromboprophylaxis
Venous thromboembolism
Descripción
Sumario:[Background] Colorectal cancer (CRC) is the third most commonly diagnosed cancer worldwide. CRC leads to increased activation of the clotting system. Since CRC patients present a higher rate of bleeding, careful evaluation of the risk/benefits of anticoagulant prophylaxis is necessary.

Similares en LA Referencia